<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7WMMLK" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Surgical Devices

Meet Puregraft®

Puregraft®, the recently integrated Bimini Health Tech solution for fat grafting.
Puregraft® makes fat grafting simple, effective and predictable. It contributes to superior patient outcomes in plastic and reconstructive surgery.1

Puregraft® by GCAesthetics®

A sterile, single-use, closed system indicated for use in the harvesting, filtering, and transfer of autologous fat grafts for plastic and reconstructive surgery.2

Benefits

High fat quality

Puregraft® gently separate lipoaspirate into purified, viable fat cells free from blood and other contaminants. The result is a high concentration of healthy, viable fat cells.3

Safe & Long-lasting

Clinically proven to deliver 95% pure fat grafts for predictable, consistent, long-lasting results every time.1,3,4

Superior results

Puregraft® delivers a fat graft with higher tissue viability and lower presence of contaminants compared to alternative methods.1

Predictable & Consistent Outcomes

Puregraft® offers a solution to address the inconsistent procedures from other techniques with its unique filtration system that provides consistent, reliable, and effective results.4

Meet the Puregraft® family of products

Puregraft® is designed for optimal efficiency with minimal waste.5 Whether you want to enhance a small area such us the hands or a larger area such us the breast or the buttocks, there is a Puregraft ™ for you.

Want to learn more?

Download the Puregraft® brochure and discover all the features and benefits of the GCA® fat grafting system.

Puregraft® brochure

Puregraft® IFU*

Contact us

0 / 500

GC Aesthetics® is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

By clicking submit below, you consent to allow GC Aesthetics® to store and process the personal information submitted above to provide you the content requested.

References

1. Min Zhu, M.D. Steven R. Cohen, M.D. Kevin C. Hicok, M.S. Rob K. Shanahan, B.S. Brian M. Strem, Ph.D. Johnson C. Yu, B.S. Douglas M. Arm, Ph.D. John K. Fraser, Ph.D. White Paper. Comparison of Three Fat Graft Preparation Methods: Gravity Separation, Centrifugation, and the Puregraft® System. (Plast. Reconstr. Surg. 131: 873, 2013.) DOI: 10.1097/PRS.0b013e31828276e9.

2. Puregraft® Instruction for use. 2023.

3. John K. Fraser Ph.D., Kevin C. Hicok, Min Zhu M.D. Composition of Puregraft Drain Fluid. Internal Data Bimini Health Tech, Puregraft, LLC. 2014. 500-029-01 Rev. A

4. Ansorge H, Garza JR, McCormack MC, et al. Autologous fat processing via the Revolve system: quality and quantity of fat retention evaluated in an animal model. Aesthet Surg J. 2014;34(3) 438-447. DOI:10.1177/1090820X14524416

5. Bimini Health Tech: https://www.biminihealthtech.com/

Important information

This form is for reporting complaints, product quality issues, or suspected adverse events relating to GC Aesthetics Products. Completing this form does not replace your legal rights or obligation to report a suspected incident directly to your healthcare provider. If you or the patient is experiencing a medical emergency or requires urgent medical attention, please contact emergency services or your treating clinician immediately rather than using this form.

Information you provide will be used by GC Aesthetics to investigate the complaint and, where required, to assess and fulfil its post-market surveillance and vigilance reporting obligations under applicable medical device legislation (including, as relevant, Regulation (EU) 2017/745 and the UK Medical Devices Regulations 2002, as amended). This may involve sharing relevant details with regulators, notified bodies, or competent authorities, as legally required. Please ensure the information provided is accurate and complete to the best of your knowledge. Submission of this form does not constitute an admission of liability or fault by GC Aesthetics, and GC Aesthetics' investigation of a complaint does not guarantee any particular outcome, remedy, or compensation.

Personal data submitted through this form will be processed in accordance with GC Aesthetics' Privacy Notice, available below https://www.gcaesthetics.com/patient-privacy-notice. GC Aesthetics aims to acknowledge receipt of complaints within 21 business days, though investigation timeframes will vary depending on complexity.